FTH — Faeth Therapeutics Share News
0.000.00%
Last trade - 00:00- $519.39m
- $332.95m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
Brief: Egle Therapeutics Appoints John Celebi As Chief Executive Officer
Sensei Biotherapeutics Q3 loss narrows; reduces workforce by 65%
U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna
Sensei falls as it scraps cancer drug development, plans to sell itself
Sensei Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Sensei Biotherapeutics Inc expected to post a loss of $5.60 a share - Earnings Preview
Brief: Sensei Biotherapeutics Announces 1-For-20 Reverse Stock Split
Sensei Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Sensei Biotherapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Sensei Biotherapeutics Inc Cash Runway Into Q2 Of 2026
Brief: Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data For Solnerstotug In PD-(L)1 Resistant Tumors
Sensei Biotherapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Sensei Biotherapeutics Provides Corporate Update And Highlights Key Upcoming Milestones
Sensei Biotherapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Sensei Biotherapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Sensei Biotherapeutics Says On Sept 17, Co Appointed Josiah Craver As Co’S Principal Financial Officer And Principal Accounting Officer